Topical PTH (1–34) is a novel, safe and effective treatment for psoriasis: a randomized self‐controlled trial and an open trial

M. Holick,F. Chimeh,S. Ray
DOI: https://doi.org/10.1046/j.1365-2133.2003.05437.x
IF: 11.113
2003-08-01
British Journal of Dermatology
Abstract:Summary  Background There continues to be a need to develop new pharmacological approaches for treating the common skin disease psoriasis. Human skin produces parathyroid hormone related peptide. This peptide is a potent inhibitor of epidermal cell growth.
What problem does this paper attempt to address?